Results
20,958 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $646K 7,255 sh | Jan 14, 2026 traded Jan 12, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $646K 7,255 sh | Jan 14, 2026 traded Jan 12, 2026 | |
Greenstreet YvonneDirector, Chief Executive Officer |
 ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale |
| SELL |
| $116K 316 sh |
| Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $217K 607 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $96K 269 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $93K 253 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $109K 301 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $193K 537 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $226K 624 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $87K 247 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $215K 584 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $94K 263 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $168K 464 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Open-market sale | SELL | $651K 40.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 31 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.66M 29.8K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.92M 21.3K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.59M 17.4K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1,654 18 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $247K 2,200 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,816 107 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $50K 545 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $5,053 55 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1,654 18 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 231 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $30K 322 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 182 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $30K 322 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF |  OLMAOlema Pharmaceuticals, Inc.Open-market sale | SELL | $429K 15.0K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 182 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 231 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $7,822 21 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $36K 94 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $79K 890 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $215K 2,419 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $33K 88 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $44K 118 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | Kao John EDirector, Chief Executive Officer |  ALHCAlignment Healthcare, Inc.Open-market sale · 10b5-1 plan | SELL | $3.74M 177.3K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 29 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $44K 118 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 28 | Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.38M 12.8K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 28 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $322K 3,648 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 28 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $322K 3,647 sh | Jan 14, 2026 traded Jan 12, 2026 |